| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mycobacterium smegmatis | 25 | 2026 | 73 | 7.650 |
Why?
|
| Cell Membrane | 16 | 2026 | 506 | 4.770 |
Why?
|
| Mycobacterium tuberculosis | 13 | 2026 | 420 | 4.030 |
Why?
|
| Cell Wall | 16 | 2026 | 118 | 3.840 |
Why?
|
| Bacterial Proteins | 17 | 2026 | 741 | 3.800 |
Why?
|
| Mycobacterium | 8 | 2023 | 37 | 3.150 |
Why?
|
| Phosphatidylinositols | 14 | 2025 | 51 | 3.000 |
Why?
|
| Mannosyltransferases | 9 | 2025 | 10 | 2.700 |
Why?
|
| Lipopolysaccharides | 10 | 2024 | 624 | 2.550 |
Why?
|
| Stress, Physiological | 5 | 2026 | 210 | 1.980 |
Why?
|
| Membrane Microdomains | 4 | 2019 | 51 | 1.740 |
Why?
|
| Mycolic Acids | 3 | 2026 | 16 | 1.170 |
Why?
|
| Inositol | 4 | 2022 | 9 | 1.160 |
Why?
|
| Mycobacterium abscessus | 2 | 2025 | 4 | 1.120 |
Why?
|
| Membrane Proteins | 6 | 2024 | 918 | 1.070 |
Why?
|
| Myocardial Infarction | 11 | 2023 | 919 | 1.050 |
Why?
|
| Acyltransferases | 2 | 2026 | 33 | 1.030 |
Why?
|
| Biofilms | 2 | 2025 | 85 | 0.980 |
Why?
|
| Peptidoglycan | 7 | 2022 | 55 | 0.930 |
Why?
|
| Proton-Motive Force | 1 | 2025 | 1 | 0.910 |
Why?
|
| Lipid Metabolism | 3 | 2016 | 225 | 0.910 |
Why?
|
| Protons | 1 | 2025 | 67 | 0.900 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2025 | 16 | 0.880 |
Why?
|
| Phytochemicals | 1 | 2025 | 22 | 0.870 |
Why?
|
| Percutaneous Coronary Intervention | 8 | 2023 | 225 | 0.820 |
Why?
|
| Cell Division | 5 | 2022 | 449 | 0.810 |
Why?
|
| Myelodysplastic Syndromes | 2 | 2022 | 93 | 0.800 |
Why?
|
| Glycolipids | 4 | 2025 | 44 | 0.790 |
Why?
|
| Dibucaine | 1 | 2023 | 2 | 0.790 |
Why?
|
| Erythropoietin | 1 | 2022 | 38 | 0.730 |
Why?
|
| Malnutrition | 1 | 2022 | 40 | 0.730 |
Why?
|
| Mannosides | 4 | 2025 | 5 | 0.720 |
Why?
|
| Anti-Bacterial Agents | 3 | 2025 | 801 | 0.720 |
Why?
|
| Stomach Neoplasms | 1 | 2022 | 81 | 0.710 |
Why?
|
| Periplasm | 2 | 2022 | 7 | 0.710 |
Why?
|
| Hypoglycemia | 1 | 2022 | 64 | 0.710 |
Why?
|
| Anemia | 1 | 2022 | 132 | 0.660 |
Why?
|
| Tuberculosis | 2 | 2023 | 308 | 0.660 |
Why?
|
| Optical Imaging | 1 | 2021 | 77 | 0.650 |
Why?
|
| Mannose | 5 | 2022 | 22 | 0.630 |
Why?
|
| Ustekinumab | 1 | 2020 | 4 | 0.630 |
Why?
|
| Immunoassay | 1 | 2020 | 71 | 0.610 |
Why?
|
| Organelles | 1 | 2019 | 20 | 0.610 |
Why?
|
| Antibodies | 1 | 2020 | 187 | 0.590 |
Why?
|
| Actinobacteria | 1 | 2019 | 8 | 0.590 |
Why?
|
| Chromatography, Thin Layer | 1 | 2019 | 16 | 0.580 |
Why?
|
| Chemical Fractionation | 1 | 2019 | 11 | 0.580 |
Why?
|
| Glycosylphosphatidylinositols | 4 | 2014 | 24 | 0.570 |
Why?
|
| Anemia, Refractory | 1 | 2018 | 2 | 0.570 |
Why?
|
| Anemia, Sideroblastic | 1 | 2018 | 2 | 0.570 |
Why?
|
| Azacitidine | 1 | 2018 | 15 | 0.570 |
Why?
|
| Crohn Disease | 1 | 2020 | 107 | 0.560 |
Why?
|
| Drug Monitoring | 1 | 2020 | 202 | 0.560 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2018 | 42 | 0.550 |
Why?
|
| Sequence Deletion | 1 | 2018 | 115 | 0.530 |
Why?
|
| Mannans | 1 | 2017 | 21 | 0.530 |
Why?
|
| Copper | 1 | 2018 | 57 | 0.520 |
Why?
|
| Ethanolamines | 1 | 2014 | 18 | 0.430 |
Why?
|
| Detergents | 2 | 2024 | 34 | 0.390 |
Why?
|
| Galactans | 2 | 2025 | 7 | 0.380 |
Why?
|
| Registries | 8 | 2022 | 925 | 0.370 |
Why?
|
| Lipids | 4 | 2025 | 328 | 0.370 |
Why?
|
| Biosynthetic Pathways | 3 | 2026 | 17 | 0.360 |
Why?
|
| Japan | 7 | 2020 | 64 | 0.360 |
Why?
|
| Humans | 31 | 2026 | 65141 | 0.360 |
Why?
|
| Hospital Mortality | 5 | 2020 | 875 | 0.350 |
Why?
|
| Fatty Acids | 2 | 2023 | 198 | 0.350 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2025 | 206 | 0.330 |
Why?
|
| Trypanosoma brucei brucei | 4 | 2014 | 14 | 0.320 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2010 | 40 | 0.320 |
Why?
|
| ST Elevation Myocardial Infarction | 2 | 2023 | 95 | 0.300 |
Why?
|
| Transcriptome | 2 | 2024 | 399 | 0.290 |
Why?
|
| Gene Deletion | 2 | 2026 | 312 | 0.290 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 2 | 2026 | 4 | 0.290 |
Why?
|
| Pyrazines | 2 | 2026 | 35 | 0.280 |
Why?
|
| Amides | 2 | 2026 | 60 | 0.280 |
Why?
|
| Aged, 80 and over | 8 | 2022 | 5614 | 0.270 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2020 | 235 | 0.270 |
Why?
|
| Animals | 15 | 2025 | 21333 | 0.260 |
Why?
|
| Phospholipids | 3 | 2017 | 81 | 0.260 |
Why?
|
| Lectins, C-Type | 3 | 2024 | 79 | 0.250 |
Why?
|
| Heme | 1 | 2026 | 30 | 0.240 |
Why?
|
| Aged | 13 | 2022 | 14963 | 0.240 |
Why?
|
| Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 2025 | 5 | 0.230 |
Why?
|
| Gene Expression Regulation, Bacterial | 3 | 2026 | 146 | 0.230 |
Why?
|
| Middle Aged | 11 | 2022 | 18273 | 0.230 |
Why?
|
| Antigens, Bacterial | 1 | 2026 | 201 | 0.230 |
Why?
|
| Trematoda | 1 | 2025 | 2 | 0.230 |
Why?
|
| Rumen | 1 | 2025 | 2 | 0.230 |
Why?
|
| Trematode Infections | 1 | 2025 | 2 | 0.230 |
Why?
|
| Iron | 1 | 2026 | 155 | 0.220 |
Why?
|
| Nitric Oxide | 1 | 2026 | 164 | 0.220 |
Why?
|
| Cattle Diseases | 1 | 2025 | 11 | 0.220 |
Why?
|
| Female | 16 | 2024 | 34030 | 0.220 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2024 | 203 | 0.220 |
Why?
|
| Wound Infection | 1 | 2025 | 29 | 0.220 |
Why?
|
| Goats | 1 | 2024 | 11 | 0.210 |
Why?
|
| Serotonergic Neurons | 1 | 2024 | 5 | 0.210 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 1 | 2024 | 7 | 0.210 |
Why?
|
| Mice | 7 | 2025 | 11114 | 0.210 |
Why?
|
| Cyclic GMP | 1 | 2024 | 33 | 0.210 |
Why?
|
| Subcellular Fractions | 2 | 2019 | 67 | 0.210 |
Why?
|
| Mycobacterium bovis | 1 | 2024 | 29 | 0.210 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2024 | 88 | 0.210 |
Why?
|
| Luteinizing Hormone | 1 | 2024 | 101 | 0.200 |
Why?
|
| Macrophages | 2 | 2024 | 1037 | 0.200 |
Why?
|
| BCG Vaccine | 1 | 2024 | 57 | 0.200 |
Why?
|
| Benzyl Alcohol | 1 | 2023 | 1 | 0.200 |
Why?
|
| Acylation | 2 | 2022 | 16 | 0.200 |
Why?
|
| Proteomics | 1 | 2025 | 293 | 0.200 |
Why?
|
| Prospective Studies | 6 | 2023 | 3310 | 0.200 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2022 | 152 | 0.200 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2026 | 278 | 0.200 |
Why?
|
| Stearic Acids | 1 | 2023 | 9 | 0.200 |
Why?
|
| Oleic Acid | 1 | 2023 | 20 | 0.200 |
Why?
|
| Male | 13 | 2022 | 31055 | 0.190 |
Why?
|
| Carbohydrate Sequence | 2 | 2018 | 21 | 0.190 |
Why?
|
| Isoniazid | 1 | 2023 | 11 | 0.190 |
Why?
|
| Periplasmic Proteins | 1 | 2022 | 2 | 0.190 |
Why?
|
| Methyltransferases | 1 | 2023 | 67 | 0.190 |
Why?
|
| Darbepoetin alfa | 1 | 2022 | 3 | 0.190 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2022 | 62 | 0.180 |
Why?
|
| Prodrugs | 1 | 2022 | 36 | 0.180 |
Why?
|
| Benzyl Alcohols | 1 | 2022 | 29 | 0.180 |
Why?
|
| Prognosis | 4 | 2020 | 1785 | 0.180 |
Why?
|
| ROC Curve | 2 | 2020 | 292 | 0.180 |
Why?
|
| Eating | 1 | 2022 | 139 | 0.180 |
Why?
|
| Mycobacterium Infections | 2 | 2019 | 15 | 0.180 |
Why?
|
| Emulsions | 1 | 2025 | 493 | 0.170 |
Why?
|
| Side-Population Cells | 1 | 2021 | 3 | 0.170 |
Why?
|
| Glucose | 1 | 2024 | 476 | 0.170 |
Why?
|
| Endometrium | 1 | 2021 | 31 | 0.170 |
Why?
|
| Protein Domains | 1 | 2021 | 153 | 0.160 |
Why?
|
| Treatment Outcome | 6 | 2023 | 5790 | 0.160 |
Why?
|
| Catheter Ablation | 1 | 2022 | 156 | 0.160 |
Why?
|
| Troponin | 1 | 2020 | 39 | 0.160 |
Why?
|
| Click Chemistry | 1 | 2020 | 10 | 0.160 |
Why?
|
| Escherichia coli | 2 | 2023 | 714 | 0.160 |
Why?
|
| Dietary Supplements | 1 | 2022 | 236 | 0.160 |
Why?
|
| Repressor Proteins | 1 | 2022 | 351 | 0.160 |
Why?
|
| Blood Glucose | 1 | 2022 | 497 | 0.160 |
Why?
|
| Serum Albumin | 1 | 2020 | 47 | 0.150 |
Why?
|
| Membrane Lipids | 1 | 2019 | 25 | 0.150 |
Why?
|
| Age Factors | 2 | 2020 | 1585 | 0.150 |
Why?
|
| Up-Regulation | 1 | 2020 | 374 | 0.150 |
Why?
|
| Models, Chemical | 2 | 2014 | 137 | 0.150 |
Why?
|
| Time-to-Treatment | 1 | 2020 | 134 | 0.150 |
Why?
|
| Chloroform | 1 | 2019 | 4 | 0.150 |
Why?
|
| Methanol | 1 | 2019 | 10 | 0.150 |
Why?
|
| Postpartum Period | 1 | 2021 | 189 | 0.150 |
Why?
|
| Protein Structure, Tertiary | 2 | 2014 | 676 | 0.150 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 170 | 0.140 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 214 | 0.140 |
Why?
|
| Solvents | 1 | 2019 | 60 | 0.140 |
Why?
|
| Blood Component Transfusion | 1 | 2018 | 11 | 0.140 |
Why?
|
| Febrile Neutropenia | 1 | 2018 | 6 | 0.140 |
Why?
|
| Cell-Free System | 2 | 2010 | 32 | 0.140 |
Why?
|
| Alanine | 1 | 2018 | 48 | 0.140 |
Why?
|
| Mutation | 5 | 2022 | 2661 | 0.140 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2018 | 56 | 0.140 |
Why?
|
| Vascular Patency | 1 | 2018 | 134 | 0.140 |
Why?
|
| Heart Failure | 3 | 2020 | 957 | 0.140 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2018 | 35 | 0.140 |
Why?
|
| Cell Fractionation | 1 | 2018 | 32 | 0.140 |
Why?
|
| Peripheral Arterial Disease | 1 | 2020 | 165 | 0.140 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 296 | 0.130 |
Why?
|
| Homeostasis | 1 | 2020 | 378 | 0.130 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2017 | 18 | 0.130 |
Why?
|
| Thrombocytopenia | 1 | 2018 | 56 | 0.130 |
Why?
|
| Arachidonic Acid | 1 | 2017 | 38 | 0.130 |
Why?
|
| Drug-Eluting Stents | 1 | 2018 | 68 | 0.130 |
Why?
|
| Coronary Vessels | 1 | 2018 | 125 | 0.130 |
Why?
|
| Disease Models, Animal | 1 | 2025 | 2293 | 0.130 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2018 | 96 | 0.130 |
Why?
|
| Thrombolytic Therapy | 1 | 2018 | 195 | 0.130 |
Why?
|
| Ultrasonography, Interventional | 1 | 2018 | 123 | 0.130 |
Why?
|
| Lactosylceramides | 1 | 2016 | 2 | 0.130 |
Why?
|
| Biomarkers | 2 | 2020 | 1480 | 0.130 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2018 | 122 | 0.120 |
Why?
|
| Atrial Fibrillation | 2 | 2022 | 879 | 0.120 |
Why?
|
| Symptom Assessment | 1 | 2016 | 48 | 0.120 |
Why?
|
| Adult | 4 | 2022 | 17358 | 0.120 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 2016 | 6 | 0.120 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 2016 | 5 | 0.120 |
Why?
|
| Feasibility Studies | 1 | 2018 | 587 | 0.120 |
Why?
|
| Tomography, Optical Coherence | 1 | 2018 | 235 | 0.120 |
Why?
|
| Receptors, Immunologic | 1 | 2016 | 179 | 0.120 |
Why?
|
| Th1 Cells | 1 | 2016 | 171 | 0.120 |
Why?
|
| Host-Pathogen Interactions | 1 | 2018 | 279 | 0.120 |
Why?
|
| Tachycardia, Ventricular | 1 | 2017 | 131 | 0.110 |
Why?
|
| Phenotype | 2 | 2018 | 1232 | 0.110 |
Why?
|
| Antigens, CD | 1 | 2016 | 342 | 0.110 |
Why?
|
| Phagocytosis | 1 | 2016 | 257 | 0.110 |
Why?
|
| Ethanolaminephosphotransferase | 1 | 2014 | 1 | 0.110 |
Why?
|
| Monomeric Clathrin Assembly Proteins | 1 | 2014 | 4 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2014 | 32 | 0.110 |
Why?
|
| Elementary Particles | 1 | 2014 | 3 | 0.110 |
Why?
|
| Magnetic Fields | 1 | 2014 | 4 | 0.110 |
Why?
|
| Proteins | 1 | 2020 | 764 | 0.110 |
Why?
|
| Coronary Angiography | 3 | 2020 | 212 | 0.100 |
Why?
|
| Protein Binding | 2 | 2018 | 1639 | 0.100 |
Why?
|
| Embryo, Mammalian | 1 | 2014 | 158 | 0.100 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2016 | 250 | 0.100 |
Why?
|
| Neutrophils | 1 | 2016 | 390 | 0.100 |
Why?
|
| Molecular Sequence Data | 3 | 2006 | 1979 | 0.100 |
Why?
|
| Endosomes | 1 | 2014 | 180 | 0.100 |
Why?
|
| beta-Lactams | 1 | 2013 | 11 | 0.100 |
Why?
|
| Models, Biological | 2 | 2011 | 1192 | 0.100 |
Why?
|
| Microbial Viability | 1 | 2013 | 56 | 0.100 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2014 | 299 | 0.090 |
Why?
|
| Cattle | 2 | 2025 | 320 | 0.090 |
Why?
|
| Fibroblasts | 1 | 2014 | 422 | 0.090 |
Why?
|
| Immunity, Innate | 1 | 2018 | 822 | 0.090 |
Why?
|
| Evolution, Molecular | 1 | 2014 | 349 | 0.090 |
Why?
|
| Neuraminidase | 1 | 2011 | 43 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 3 | 2016 | 3481 | 0.090 |
Why?
|
| Survival Rate | 3 | 2018 | 844 | 0.090 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2011 | 48 | 0.080 |
Why?
|
| Oxalic Acid | 1 | 2010 | 1 | 0.080 |
Why?
|
| Glycoproteins | 1 | 2011 | 189 | 0.080 |
Why?
|
| Cell Line | 1 | 2014 | 2023 | 0.080 |
Why?
|
| Salts | 1 | 2010 | 14 | 0.080 |
Why?
|
| Leishmania | 1 | 2010 | 12 | 0.080 |
Why?
|
| Cord Factors | 1 | 2009 | 1 | 0.080 |
Why?
|
| Nucleotides | 1 | 2010 | 48 | 0.080 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2010 | 223 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2006 | 364 | 0.070 |
Why?
|
| Mass Spectrometry | 1 | 2010 | 295 | 0.070 |
Why?
|
| Protozoan Proteins | 2 | 2006 | 132 | 0.070 |
Why?
|
| Catalysis | 2 | 2022 | 163 | 0.070 |
Why?
|
| Cell Cycle | 2 | 2021 | 398 | 0.070 |
Why?
|
| Lipoproteins | 1 | 2008 | 85 | 0.070 |
Why?
|
| Sequence Alignment | 2 | 2025 | 300 | 0.070 |
Why?
|
| Phosphorylation | 1 | 2010 | 962 | 0.070 |
Why?
|
| Stroke | 3 | 2021 | 1211 | 0.060 |
Why?
|
| Cell Proliferation | 2 | 2014 | 1036 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2020 | 147 | 0.060 |
Why?
|
| Operon | 1 | 2026 | 31 | 0.060 |
Why?
|
| Life Cycle Stages | 1 | 2006 | 20 | 0.060 |
Why?
|
| Genome, Bacterial | 1 | 2006 | 66 | 0.060 |
Why?
|
| Amino Acid Sequence | 2 | 2006 | 1589 | 0.060 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2006 | 45 | 0.060 |
Why?
|
| Phosphates | 1 | 2006 | 104 | 0.060 |
Why?
|
| Genes, Bacterial | 1 | 2006 | 115 | 0.060 |
Why?
|
| Phosphatidylethanolamines | 1 | 2005 | 19 | 0.060 |
Why?
|
| Hemagglutinins | 1 | 2005 | 17 | 0.060 |
Why?
|
| RNA, Ribosomal, 28S | 1 | 2025 | 3 | 0.060 |
Why?
|
| DNA, Helminth | 1 | 2025 | 10 | 0.060 |
Why?
|
| Protein Subunits | 1 | 2006 | 169 | 0.060 |
Why?
|
| Cambodia | 1 | 2025 | 28 | 0.060 |
Why?
|
| Electron Transport Complex IV | 1 | 2025 | 16 | 0.060 |
Why?
|
| Adaptation, Physiological | 1 | 2026 | 131 | 0.060 |
Why?
|
| Incidence | 2 | 2020 | 1419 | 0.060 |
Why?
|
| Odds Ratio | 2 | 2017 | 754 | 0.060 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2026 | 134 | 0.050 |
Why?
|
| Haplotypes | 1 | 2025 | 134 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2005 | 254 | 0.050 |
Why?
|
| Dorsal Raphe Nucleus | 1 | 2024 | 2 | 0.050 |
Why?
|
| DNA, Mitochondrial | 1 | 2025 | 86 | 0.050 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 2024 | 18 | 0.050 |
Why?
|
| Polyisoprenyl Phosphate Monosaccharides | 1 | 2004 | 1 | 0.050 |
Why?
|
| Kisspeptins | 1 | 2024 | 25 | 0.050 |
Why?
|
| Biochemistry | 1 | 2005 | 51 | 0.050 |
Why?
|
| Guanosine Diphosphate | 1 | 2004 | 19 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2025 | 341 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2014 | 3149 | 0.050 |
Why?
|
| Serotonin | 1 | 2024 | 62 | 0.050 |
Why?
|
| Rats | 2 | 2024 | 1994 | 0.050 |
Why?
|
| Phylogeny | 1 | 2025 | 388 | 0.050 |
Why?
|
| Time-Lapse Imaging | 1 | 2022 | 21 | 0.050 |
Why?
|
| Cryoelectron Microscopy | 1 | 2025 | 217 | 0.050 |
Why?
|
| Sick Sinus Syndrome | 1 | 2022 | 5 | 0.050 |
Why?
|
| Cloning, Molecular | 3 | 2011 | 384 | 0.050 |
Why?
|
| Time Factors | 2 | 2023 | 3762 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2025 | 394 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2024 | 624 | 0.050 |
Why?
|
| Cytokinesis | 1 | 2022 | 41 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2021 | 1386 | 0.050 |
Why?
|
| Methylation | 1 | 2022 | 130 | 0.050 |
Why?
|
| Penicillin-Binding Proteins | 1 | 2022 | 9 | 0.050 |
Why?
|
| Pregnancy | 2 | 2021 | 2374 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2025 | 1162 | 0.040 |
Why?
|
| Microarray Analysis | 1 | 2021 | 64 | 0.040 |
Why?
|
| Angina, Unstable | 1 | 2020 | 56 | 0.040 |
Why?
|
| Stromal Cells | 1 | 2021 | 78 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2024 | 794 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2022 | 342 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2016 | 2156 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2022 | 285 | 0.040 |
Why?
|
| Myocardial Revascularization | 1 | 2020 | 78 | 0.040 |
Why?
|
| Secondary Prevention | 1 | 2021 | 165 | 0.040 |
Why?
|
| Cytokines | 1 | 2024 | 952 | 0.040 |
Why?
|
| Hospitalization | 2 | 2017 | 1392 | 0.040 |
Why?
|
| Mortality | 1 | 2020 | 161 | 0.040 |
Why?
|
| Risk Factors | 2 | 2021 | 5430 | 0.040 |
Why?
|
| Recurrence | 1 | 2020 | 657 | 0.040 |
Why?
|
| Penicillins | 1 | 2018 | 32 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2022 | 519 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2018 | 67 | 0.040 |
Why?
|
| Guideline Adherence | 1 | 2020 | 307 | 0.030 |
Why?
|
| Dipeptides | 1 | 2018 | 68 | 0.030 |
Why?
|
| Sex Factors | 1 | 2020 | 991 | 0.030 |
Why?
|
| Hospitals | 1 | 2020 | 386 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 244 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1282 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2017 | 205 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 736 | 0.030 |
Why?
|
| Chest Pain | 1 | 2016 | 85 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2018 | 554 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 402 | 0.030 |
Why?
|
| Escherichia coli Proteins | 1 | 2018 | 277 | 0.030 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2017 | 191 | 0.030 |
Why?
|
| Clathrin-Coated Vesicles | 1 | 2014 | 8 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 128 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2016 | 197 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 233 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2016 | 752 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 2102 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 882 | 0.030 |
Why?
|
| Biological Transport | 1 | 2014 | 292 | 0.030 |
Why?
|
| Thermodynamics | 1 | 2014 | 196 | 0.030 |
Why?
|
| Endocytosis | 1 | 2014 | 152 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2014 | 610 | 0.020 |
Why?
|
| Temperature | 1 | 2014 | 316 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2014 | 662 | 0.020 |
Why?
|
| Membrane Glycoproteins | 2 | 2006 | 662 | 0.020 |
Why?
|
| Amino Sugars | 1 | 2011 | 2 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 555 | 0.020 |
Why?
|
| Hypertension | 1 | 2016 | 612 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 2188 | 0.020 |
Why?
|
| Granuloma | 1 | 2009 | 43 | 0.020 |
Why?
|
| Receptors, IgG | 1 | 2009 | 41 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 2763 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2009 | 115 | 0.020 |
Why?
|
| Apoptosis | 1 | 2014 | 1100 | 0.020 |
Why?
|
| Ligands | 1 | 2009 | 415 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2009 | 183 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 4812 | 0.020 |
Why?
|
| Adolescent | 1 | 2017 | 6306 | 0.020 |
Why?
|
| Disulfides | 1 | 2006 | 67 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2006 | 77 | 0.010 |
Why?
|
| Virulence | 1 | 2006 | 199 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2017 | 6865 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 2004 | 49 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2004 | 84 | 0.010 |
Why?
|
| Multiprotein Complexes | 1 | 2006 | 156 | 0.010 |
Why?
|
| CHO Cells | 1 | 2004 | 192 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2004 | 173 | 0.010 |
Why?
|
| DNA Primers | 1 | 2004 | 301 | 0.010 |
Why?
|
| Cricetinae | 1 | 2004 | 362 | 0.010 |
Why?
|
| Glioma | 1 | 2004 | 101 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 1566 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2006 | 1575 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2004 | 570 | 0.010 |
Why?
|